Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 8160

1.

Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease.

Vella LJ, Hill AF, Cheng L.

Int J Mol Sci. 2016 Feb 6;17(2). pii: E173. doi: 10.3390/ijms17020173. Review.

PMID:
26861304
2.

Neuroimaging genetic risk for Alzheimer's disease in preclinical individuals: From candidate genes to polygenic approaches.

Harrison TM, Bookheimer SY.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Jan 1;1(1):14-23.

PMID:
26858991
3.

Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease.

Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, Rainey-Smith S, Lautenschlager N, Rowe CC, Savage G, Villemagne VL, Ellis KA; AIBL study.

Alzheimers Dement. 2016 Feb 4. pii: S1552-5260(16)00015-7. doi: 10.1016/j.jalz.2015.12.013. [Epub ahead of print]

PMID:
26852195
4.

Nano-biosensors to detect beta-amyloid for Alzheimer's disease management.

Kaushik A, Jayant RD, Tiwari S, Vashist A, Nair M.

Biosens Bioelectron. 2016 Jan 28;80:273-287. doi: 10.1016/j.bios.2016.01.065. [Epub ahead of print] Review.

PMID:
26851586
5.

Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Kovacs GG.

Int J Mol Sci. 2016 Feb 2;17(2). pii: E189. doi: 10.3390/ijms17020189. Review.

6.

A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease.

Li N, Liu Y, Li W, Zhou L, Li Q, Wang X, He P.

J Ginseng Res. 2016 Jan;40(1):9-17. doi: 10.1016/j.jgr.2015.04.006. Epub 2015 Apr 30.

7.

Sex differences in the association between AD biomarkers and cognitive decline.

Koran ME, Wagener M, Hohman TJ; Alzheimer’s Neuroimaging Initiative.

Brain Imaging Behav. 2016 Feb 3. [Epub ahead of print]

PMID:
26843008
8.

Default Mode Network Functional Connectivity in Early and Late Mild Cognitive Impairment: Results From the Alzheimer's Disease Neuroimaging Initiative.

Lee ES, Yoo K, Lee YB, Chung J, Lim JE, Yoon B, Jeong Y; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimer Dis Assoc Disord. 2016 Feb 2. [Epub ahead of print]

PMID:
26840545
9.

Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.

Butterfield DA, Palmieri EM, Castegna A.

Expert Rev Proteomics. 2016 Feb 3. [Epub ahead of print]

PMID:
26837425
10.

Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model.

Manousopoulou A, Saito S, Yamamoto Y, Al-Daghri NM, Ihara M, Carare RO, Garbis SD.

J Alzheimers Dis. 2016 Jan 21. [Epub ahead of print]

PMID:
26836196
11.

Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.

Niemantsverdriet E, Goossens J, Struyfs H, Martin JJ, Goeman J, Deyn PP, Vanderstichele H, Engelborghs S.

J Alzheimers Dis. 2016 Jan 19. [Epub ahead of print]

PMID:
26836187
12.

Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study.

Chatterjee P, Lim WL, Shui G, Gupta VB, James I, Fagan AM, Xiong C, Sohrabi HR, Taddei K, Brown BM, Benzinger T, Masters C, Snowden SG, Wenk MR, Bateman RJ, Morris JC, Martins RN.

J Alzheimers Dis. 2016 Jan 21. [Epub ahead of print]

PMID:
26836186
13.

Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.

Wang J, Tan L, Yu JT.

J Alzheimers Dis. 2016 Jan 19. [Epub ahead of print]

PMID:
26836177
14.

Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.

Wang HF, Tan L, Cao L, Zhu XC, Jiang T, Tan MS, Liu Y, Wang C, Tsai RM, Jia JP, Yu JT.

J Alzheimers Dis. 2016 Jan 21. [Epub ahead of print]

PMID:
26836176
15.
16.
17.
18.

Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes.

Weston PS, Paterson RW, Modat M, Burgos N, Cardoso MJ, Magdalinou N, Lehmann M, Dickson JC, Barnes A, Bomanji JB, Kayani I, Cash DM, Ourselin S, Toombs J, Lunn MP, Mummery CJ, Warren JD, Rossor MN, Fox NC, Zetterberg H, Schott JM.

Alzheimers Dement (Amst). 2015 Nov 2;1(4):440-446. eCollection 2015 Dec.

19.

Novel Therapeutic Strategies for Dementia.

Cacabelos R, Torrellas C, Carrera I, Cacabelos P, Corzo L, Fernández-Novoa L, Tellado I, Carril JC, Aliev G.

CNS Neurol Disord Drug Targets. 2016 Feb 2. [Epub ahead of print]

PMID:
26831267
20.

Prefrontal white matter pathology in air pollution exposed Mexico City young urbanites and their potential impact on neurovascular unit dysfunction and the development of Alzheimer's disease.

Calderón-Garcidueñas L, Reynoso-Robles R, Vargas-Martínez J, Gómez-Maqueo-Chew A, Pérez-Guillé B, Mukherjee PS, Torres-Jardón R, Perry G, Gónzalez-Maciel A.

Environ Res. 2016 Jan 29;146:404-417. doi: 10.1016/j.envres.2015.12.031. [Epub ahead of print]

PMID:
26829765
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk